Huadong Financial Statements From 2010 to 2025

000963 Stock   32.63  0.25  0.77%   
Huadong Medicine financial statements provide useful quarterly and yearly information to potential Huadong Medicine Co investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Huadong Medicine financial statements helps investors assess Huadong Medicine's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Huadong Medicine's valuation are summarized below:
Gross Profit
12 B
Profit Margin
0.077
Market Capitalization
57.6 B
Enterprise Value Revenue
1.3051
Revenue
41.7 B
We have found eighty available fundamental trends for Huadong Medicine, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of Huadong Medicine regular market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road.

Huadong Medicine Total Revenue

49.05 Billion

Check Huadong Medicine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Huadong Medicine's main balance sheet or income statement drivers, such as Interest Expense of 138.7 M, Selling General Administrative of 6.1 B or Total Revenue of 49.1 B, as well as many indicators such as . Huadong financial statements analysis is a perfect complement when working with Huadong Medicine Valuation or Volatility modules.
  
This module can also supplement various Huadong Medicine Technical models . Check out the analysis of Huadong Medicine Correlation against competitors.

Huadong Medicine Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets40.5 B38.5 B19.2 B
Slightly volatile
Other Current Liabilities17.5 M18.4 M919.8 M
Pretty Stable
Total Current Liabilities13 B12.4 B7.4 B
Slightly volatile
Total Stockholder Equity25.4 B24.2 B10.6 B
Slightly volatile
Other Liabilities687.6 M654.8 M253.2 M
Slightly volatile
Retained Earnings19 B18 B7.5 B
Slightly volatile
Accounts Payable7.4 BB4.1 B
Slightly volatile
Cash5.6 B5.4 B2.6 B
Slightly volatile
Other Assets1.3 B1.2 B523.8 M
Slightly volatile
Net ReceivablesB8.6 B5.5 B
Slightly volatile
Short Term Investments821.1 M782 M423.6 M
Slightly volatile
Inventory5.2 B4.9 B3.1 B
Slightly volatile
Other Current Assets65.4 M68.9 M261.9 M
Very volatile
Total Liabilities14.4 B13.7 B8.2 B
Slightly volatile
Intangible AssetsB3.8 B1.4 B
Slightly volatile
Common Stock2.1 BB1.1 B
Slightly volatile
Property Plant Equipment6.1 B5.8 BB
Slightly volatile
Long Term Debt489.6 M598.9 M485.1 M
Slightly volatile
Good Will3.1 BB1.1 B
Slightly volatile
Net Tangible AssetsB14 B7.4 B
Slightly volatile
Deferred Long Term Liabilities10.1 M11.2 M12.7 M
Slightly volatile
Long Term Investments177.7 M207 M165.8 M
Slightly volatile
Short and Long Term Debt808.2 M945.7 M540.9 M
Slightly volatile
Total Current Assets15.5 B21.3 B13 B
Slightly volatile
Short Term Debt421.3 M719.6 M380.6 M
Slightly volatile
Non Current Assets Total9.6 B17.3 B7.1 B
Slightly volatile
Non Currrent Assets Other1.9 B1.8 B554.4 M
Slightly volatile
Non Current Liabilities Total1.1 B1.3 BB
Very volatile
Non Current Liabilities Other72.1 M75.9 M536.1 M
Slightly volatile
Common Stock Shares Outstanding1.9 BB1.8 B
Slightly volatile
Net Invested Capital17.5 B25.7 B13.9 B
Slightly volatile
Net Working Capital7.1 B8.8 B6.7 B
Slightly volatile
Capital Stock1.9 BB1.6 B
Slightly volatile
Property Plant And Equipment Net5.2 BB4.4 B
Slightly volatile
Property Plant And Equipment Gross6.8 BBB
Slightly volatile
Capital Lease Obligations66.9 M51 M98.4 M
Slightly volatile

Huadong Medicine Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative6.1 B5.9 B4.2 B
Slightly volatile
Total Revenue49.1 B46.7 B27.9 B
Slightly volatile
Operating Income4.5 B4.3 B2.4 B
Slightly volatile
Cost Of Revenue33.2 B31.6 B19.8 B
Slightly volatile
Income Before Tax4.2 BB2.3 B
Slightly volatile
Net Income Applicable To Common Shares2.8 B2.6 B1.7 B
Slightly volatile
Net Income3.4 B3.3 B1.8 B
Slightly volatile
Income Tax Expense590.4 M562.2 M373 M
Slightly volatile
Research Development809.4 M1.5 B651.5 M
Slightly volatile
Gross Profit10.5 B15.1 B8.6 B
Slightly volatile
Other Operating Expenses183.8 M236.1 M159.4 M
Slightly volatile
Net Income From Continuing Ops2.5 B3.3 BB
Slightly volatile
EBIT2.9 B3.6 B2.4 B
Slightly volatile
Total Operating Expenses32 B42.4 B27.3 B
Slightly volatile
Tax Provision543.9 M712.5 M455.8 M
Slightly volatile
Interest Income64 M108.2 M50.7 M
Slightly volatile
EBITDA3.9 B4.4 B3.3 B
Slightly volatile
Reconciled Depreciation555.2 M931 M432.6 M
Slightly volatile

Huadong Medicine Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Dividends Paid354.3 M683.3 M475.7 M
Slightly volatile
Capital Expenditures1.9 B1.8 B852.9 M
Slightly volatile
Total Cash From Operating Activities4.7 B4.5 BB
Slightly volatile
Net Income3.4 B3.3 B1.8 B
Slightly volatile
Depreciation476 M931 M381 M
Slightly volatile
End Period Cash Flow3.3 B4.8 BB
Slightly volatile
Free Cash Flow1.7 B2.7 B1.5 B
Slightly volatile
Begin Period Cash Flow3.1 B3.9 B2.8 B
Slightly volatile
Other Non Cash Items112 M134.5 M96 M
Slightly volatile

About Huadong Medicine Financial Statements

Huadong Medicine stakeholders use historical fundamental indicators, such as Huadong Medicine's revenue or net income, to determine how well the company is positioned to perform in the future. Although Huadong Medicine investors may analyze each financial statement separately, they are all interrelated. For example, changes in Huadong Medicine's assets and liabilities are reflected in the revenues and expenses on Huadong Medicine's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Huadong Medicine Co. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue46.7 B49.1 B
Cost Of Revenue31.6 B33.2 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Huadong Stock

Huadong Medicine financial ratios help investors to determine whether Huadong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Huadong with respect to the benefits of owning Huadong Medicine security.